1. Blair, J. A., Morar, C., Hamon, C. G. B., Al-Salihi, J., Barford, P. A., Pheasant, A. E., Whitburn, S. B., Leeming, R. J., & Coppen, A. (1984). Tetrahydrobiopterin in depression.Lancet, 1, 163.
2. Campbell, M., Small, A. M., Palij, M., Perry, R., Polonsky, B. B., Lukashok, D., & Anderson, L. T. (1987). The efficacy and safety of fenfluramine in autistic children: preliminary analysis of a double-blind study.Psychopharmacological Bulletin, 23, 123–127.
3. Curtius, H. C., Muldner, H., & Niederwieser, A. (1982a). Endogenous depression and Parkinson's disease. Therapeutic trials with tetrahydrobiopterin. In H. Wachter, H. C. Curtius, & W. Pfleiderer (Eds.),Biochemical and clinical aspects of pteridines (Vol. 1, pp. 285–292). New York: Walter de Gruyter.
4. Curtius, H. C., Muldner, H., & Niederwieser, A. (1982b). Tetrahydrobiopterin: efficacy in endogenous depression and Parkinson's disease.Journal of Neural Transmission, 55, 301–308.
5. Curtius, H. C., Niederwieser, A., Levine, R., & Muldner, H. (1984). Therapeutic efficacy of tetrahydrobiopterin in Parkinson's disease.Advances in Neurology, 50, 463.